Amgen vs Caris Life Sciences
Amgen vs Caris Life Sciences, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amgen is on 34/100 and Caris Life Sciences on 59/100.
Where each one leads
Amgen
- domain rating: 80/100 against 63/100
- headcount: 39,919 against 1,659
- LinkedIn following: 1,697,311 against 77,698
Caris Life Sciences
- our overall score: 59/100 against 34/100
- agent readiness: 47/100 against 41/100
- funding raised: $700M against $40.0M
At a glance
| Measure | Amgen | Caris Life Sciences |
|---|---|---|
| What it is | A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 1980 | 2008 |
| Headquarters | Thousand Oaks, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Amgen | Caris Life Sciences |
|---|---|---|
| Employees | 39,919 | 1,659 |
| Total funding | $40.0M | $700M |
| Latest round | IPO | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | 1,697,311 | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amgen | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 59/100 |
| Traction | 58/100 | 60/100 |
| Team | 70/100 | Not published |
| Community | 8/100 | Not published |
| Search visibility | 68/100 | 22/100 |
| Quality | 15/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amgen | Caris Life Sciences |
|---|---|---|
| Hosting | AWS | Self Managed |
| CDN | CloudFront | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Amgen vs Caris Life Sciences: common questions
Which is better, Amgen or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Amgen and Caris Life Sciences compare on the numbers?
Amgen leads on domain rating (80/100 against 63/100), headcount (39,919 against 1,659), LinkedIn following (1,697,311 against 77,698). Caris Life Sciences leads on our overall score (59/100 against 34/100), agent readiness (47/100 against 41/100), funding raised ($700M against $40.0M).
Read the full Amgen review and pricing or the Caris Life Sciences review and pricing. You can also browse other Amgen alternatives we track.